Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.
about
Azithromycin: indications for the future?Heat shock protein 10 of Chlamydophila pneumoniae induces proinflammatory cytokines through Toll-like receptor (TLR) 2 and TLR4 in human monocytes THP-1.Serological Evidence of Chronic Chlamydia pneumoniae Infection in Coronary Artery Disease.Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones.
P2860
Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antimicrobial therapy for Chla ...... in atherosclerosis and asthma.
@ast
Antimicrobial therapy for Chla ...... in atherosclerosis and asthma.
@en
type
label
Antimicrobial therapy for Chla ...... in atherosclerosis and asthma.
@ast
Antimicrobial therapy for Chla ...... in atherosclerosis and asthma.
@en
prefLabel
Antimicrobial therapy for Chla ...... in atherosclerosis and asthma.
@ast
Antimicrobial therapy for Chla ...... in atherosclerosis and asthma.
@en
P2860
P356
P1476
Antimicrobial therapy for Chla ...... in atherosclerosis and asthma.
@en
P2093
P2860
P304
P356
10.1093/JAC/44.2.145
P407
P577
1999-08-01T00:00:00Z